Floating Button
Home Capital Broker's Calls

'A transitional year' for Thomson Medical Group, as Maybank lowers target price to 6 cents

Nicole Lim
Nicole Lim • 2 min read
'A transitional year' for Thomson Medical Group, as Maybank lowers target price to 6 cents
The group has incurred higher-than-expected opex and finance costs after its Vietnam hospital acquisition, says analyst Eric Ong. Photo: The Edge Singapore
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Maybank Securities’ Eric Ong has lowered his target price for Thomson Medical Group (SGX:A50) from 8 cents to 6 cents, following the group’s FY2024 results ended June which saw a 57.8% y-o-y lower earnings of $15.4 million.

However, Ong has kept his “buy” call on the healthcare group. The analyst says that the group’s headline patmi of $13.4 million for the 2HFY2024 came in below his projections mainly due to higher-than-expected opex and finance costs. The higher-than-expected costs came after the group completed its acquisition of FV Hospital in Vietnam in January.

The analyst notes that revenue rose 6.6% y-o-y to $183 million for the second half on the back of topline contribution of $50.4 million from the Vietnam hospital, which provides a “strong addition”. 

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.